Nanoparticle-Based Therapeutic Strategies for Pathological Cardiac Hypertrophy: Preclinical Advances, Translational Challenges, and Future Perspectives
International Journal of Nanomedicine · 2026
DOI: 10.2147/ijn.s619643 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Mengyue Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center of Gerontology and Geriatrics, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, People's Re…. Hauptthemen laut MEDLINE: Cardiomegaly, Nanoparticles, Nanoparticle Drug Delivery System. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Gerontology and Geriatrics, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
ORCID-Profile: Mengyue Yang
Zitieren
APA
Yang, M., & Wu, J. (2026). Nanoparticle-Based Therapeutic Strategies for Pathological Cardiac Hypertrophy: Preclinical Advances, Translational Challenges, and Future Perspectives. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s619643
Vancouver
Yang M, Wu J. Nanoparticle-Based Therapeutic Strategies for Pathological Cardiac Hypertrophy: Preclinical Advances, Translational Challenges, and Future Perspectives. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s619643
BibTeX
@article{Yang2026,
author = {Yang, Mengyue and Wu, Jinhui},
title = {Nanoparticle-Based Therapeutic Strategies for Pathological Cardiac Hypertrophy: Preclinical Advances, Translational Challenges, and Future Perspectives},
journal = {International Journal of Nanomedicine},
year = {2026},
doi = {10.2147/ijn.s619643}
}
EUVIMED